Last Updated: June 25, 2026

CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER Drug Patent Profile

Name: CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Cefuroxime And Dextrose In Duplex Container, and what generic alternatives are available?

Cefuroxime And Dextrose In Duplex Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER is cefuroxime sodium. There are sixty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cefuroxime sodium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Cefuroxime And Dextrose In Duplex Container

A generic version of CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER was approved as cefuroxime sodium by ACS DOBFAR SPA on May 30^th, 1997.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER?
What are the global sales for CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER?
What is Average Wholesale Price for CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER?

Summary for CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	61
Patent Applications:	561
DailyMed Link:	CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER at DailyMed

Drug patent expirations by year for CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER

Pharmacology for CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER

Drug Class	Cephalosporin Antibacterial

US Patents and Regulatory Information for CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun	CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER	cefuroxime sodium	INJECTABLE;INJECTION	050780-002	Feb 21, 2001		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
B Braun	CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER	cefuroxime sodium	INJECTABLE;INJECTION	050780-001	Feb 21, 2001		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.